solifenacin succinate 10 MG Oral Tablet

1 INDICATIONS AND USAGE Solifenacin succinate tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin succinate tablets are a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency ( 1 ).

teva pharmaceuticals usa, inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] toxicity to various agents` `[3] completed suicide` `[4] off label use` `[5] fatigue` `[6] nausea` `[7] drug abuse` `[8] headache` `[9] pain` `[10] diarrhoea`

4 years ago

ROUND PINK TV 3N

16 HOW SUPPLIED/STORAGE AND HANDLING Solifenacin Succinate Tablets are available as follows: 5 mg – white, round, standard, normal convex, film-coated, unscored tablets, debossed with “TV” on one side of the tablet and with “2N” on the other side and are available in bottles of 30 (NDC 0093-5263-56) and 90 (NDC 0093-5263-98) tablets. 10 mg – light-pink to pink, round, standard, normal convex, film-coated, unscored tablets, debossed with “TV” on one side of the tablet and with “3N” on the other side and are available in bottles of 30 (NDC 0093-5264-56) and 90 (NDC 0093-5264-98) tablets. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required)

More pills like ROUND TV 3N

Related Pills

solifenacin succinate 5 MG Oral Tablet

teva pharmaceuticals usa, inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site